Home Logon FTA Investment Managers Blog Subscribe About Us Contact Us

Search by Ticker, Keyword or CUSIP       
 
 
First Trust Indxx Medical Devices ETF (MDEV)
Holdings of the Fund as of 5/6/2026
View Index Holdings

Total Number of Holdings (excluding cash): 51

Security Name Identifier CUSIP Shares / Quantity Market Value Weighting Descending sort
West Pharmaceutical Services, Inc. WST 955306105 150 $46,882.50 2.52%
Demant A/S DEMANT.DC K3008M105 1,240 $45,248.59 2.43%
Revvity, Inc. RVTY 714046109 430 $42,608.70 2.29%
Waters Corporation WAT 941848103 121 $42,293.13 2.27%
Edwards Lifesciences Corporation EW 28176E108 495 $41,184.00 2.21%
LivaNova Plc LIVN G5509L101 615 $40,749.90 2.19%
Straumann Holding AG (Registered) STMN.SW H8300N127 361 $40,776.72 2.19%
WuXi AppTec Co., Ltd. (Class H) 2359.HK Y971B1118 2,285 $40,383.80 2.17%
Olympus Corporation 7733.JP J61240107 3,940 $40,206.35 2.16%
Teleflex Incorporated TFX 879369106 326 $40,172.98 2.16%
Agilent Technologies, Inc. A 00846U101 335 $39,426.15 2.12%
Sonova Holding AG (Registered) SOON.SW H8024W106 167 $39,334.97 2.11%
Carl Zeiss Meditec AG (Bearer) AFX.GY D14895102 1,268 $39,101.54 2.10%
Shanghai Microport Medbot (Group) Co., Ltd. (Class H) 2252.HK Y768JD106 10,500 $39,155.90 2.10%
Align Technology, Inc. ALGN 016255101 223 $38,788.62 2.09%
Intuitive Surgical, Inc. ISRG 46120E602 86 $38,848.78 2.09%
Masimo Corporation MASI 574795100 216 $38,552.76 2.07%
Mettler-Toledo International Inc. MTD 592688105 29 $38,484.16 2.07%
Baxter International Inc. BAX 071813109 2,250 $38,205.00 2.05%
Globus Medical, Inc. (Class A) GMED 379577208 427 $38,096.94 2.05%
Sysmex Corporation 6869.JP J7864H102 4,434 $38,047.02 2.05%
Penumbra, Inc. PEN 70975L107 117 $37,930.23 2.04%
Sartorius Stedim Biotech DIM.FP F8005V210 193 $37,940.61 2.04%
LeMaitre Vascular, Inc. LMAT 525558201 337 $37,144.14 2.00%
Coloplast A/S (Class B) COLOB.DC K16018192 574 $36,965.75 1.99%
Steris Plc STE G8473T100 173 $37,101.58 1.99%
Terumo Corporation 4543.JP J83173104 2,860 $36,925.91 1.99%
Koninklijke Philips N.V. PHIA.NA N7637U112 1,355 $36,884.99 1.98%
Thermo Fisher Scientific Inc. TMO 883556102 78 $36,890.10 1.98%
DexCom, Inc. DXCM 252131107 603 $36,397.08 1.96%
Fisher & Paykel Healthcare Corporation Limited FPH.NZ Q38992105 1,711 $36,544.93 1.96%
Siemens Healthineers AG SHL.GY D6T479107 871 $36,432.33 1.96%
Becton, Dickinson and Company BDX 075887109 250 $36,190.00 1.95%
Bio-Rad Laboratories, Inc. (Class A) BIO 090572207 138 $35,744.76 1.92%
Hoya Corporation 7741.JP J22848105 194 $35,681.16 1.92%
Danaher Corporation DHR 235851102 203 $35,508.76 1.91%
ResMed Inc. RMD 761152107 169 $35,429.16 1.90%
Boston Scientific Corporation BSX 101137107 624 $34,944.00 1.88%
Smith & Nephew Plc SN/.LN G82343164 2,299 $34,925.66 1.88%
Merit Medical Systems, Inc. MMSI 589889104 565 $34,820.95 1.87%
Medtronic Plc MDT G5960L103 442 $34,299.20 1.84%
Zimmer Biomet Holdings, Inc. ZBH 98956P102 414 $34,291.62 1.84%
Abbott Laboratories ABT 002824100 385 $33,225.50 1.79%
Stryker Corporation SYK 863667101 114 $33,325.62 1.79%
The Cooper Companies, Inc. COO 216648501 542 $33,127.04 1.78%
Alcon Inc. ALC.SW H01301128 494 $32,962.98 1.77%
GE HealthCare Technologies Inc. GEHC 36266G107 527 $32,534.36 1.75%
BioMerieux BIM.FP F1149Y232 365 $30,489.57 1.64%
Insulet Corporation PODD 45784P101 196 $29,650.88 1.59%
Cochlear Limited COH.AU Q25953102 317 $22,419.09 1.21%
US Dollar $USD 6,474 $6,473.96 0.35%
Japanese Yen $JPY 44,982 $287.59 0.02%
Swiss Franc $CHF 138 $177.61 0.01%
Euro $EUR 0 $0.06 0.00%
Pound Sterling $GBP 0 $0.15 0.00%
TPG Inc. (CVR) 2602335D 436CVR021 612 $0.00 0.00%
Holdings are subject to change.

The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.


 
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
Follow First Trust:  
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  First Trust Funds Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2026 All rights reserved.